Ricky D Shafer

Array ( [id] => 3722348 [patent_doc_number] => 05681696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Synthetic peptide compositions with immunoreactivities to antibodies to HTLV' [patent_app_type] => 1 [patent_app_number] => 8/457865 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11472 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681696.pdf [firstpage_image] =>[orig_patent_app_number] => 457865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3744447 [patent_doc_number] => 05716829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Diagnostic test for Pseudomonas aeruginosa infections' [patent_app_type] => 1 [patent_app_number] => 8/452845 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6158 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716829.pdf [firstpage_image] =>[orig_patent_app_number] => 452845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4040580 [patent_doc_number] => 05874226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'In situ immunodetection of antigens' [patent_app_type] => 1 [patent_app_number] => 8/447072 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6121 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874226.pdf [firstpage_image] =>[orig_patent_app_number] => 447072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3922634 [patent_doc_number] => 05914243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Process for the immunochemical determination of an analyte' [patent_app_type] => 1 [patent_app_number] => 8/441175 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2584 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914243.pdf [firstpage_image] =>[orig_patent_app_number] => 441175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4071465 [patent_doc_number] => 05965371 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Method of intracellular binding of target molecules' [patent_app_type] => 1 [patent_app_number] => 8/438190 [patent_app_country] => US [patent_app_date] => 1995-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 26771 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965371.pdf [firstpage_image] =>[orig_patent_app_number] => 438190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549715 [patent_doc_number] => 05518723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'HIV immunogenic complexes' [patent_app_type] => 1 [patent_app_number] => 8/437250 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 5995 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/518/05518723.pdf [firstpage_image] =>[orig_patent_app_number] => 437250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658977 [patent_doc_number] => 05648208 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Use of a collagen as solid binding substrate for a ligand capable of reacting specifically with an element to be detected in a biological medium, reactant and implementation' [patent_app_type] => 1 [patent_app_number] => 8/433805 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4362 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648208.pdf [firstpage_image] =>[orig_patent_app_number] => 433805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811075 [patent_doc_number] => 05811525 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Therapeutic and diagnostic methods using total leukocyte surface antigens' [patent_app_type] => 1 [patent_app_number] => 8/432322 [patent_app_country] => US [patent_app_date] => 1995-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16054 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811525.pdf [firstpage_image] =>[orig_patent_app_number] => 432322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725499 [patent_doc_number] => 05670311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Peptides for detecting antibodies to HTLV-2' [patent_app_type] => 1 [patent_app_number] => 8/423022 [patent_app_country] => US [patent_app_date] => 1995-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6865 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670311.pdf [firstpage_image] =>[orig_patent_app_number] => 423022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8339977 [patent_doc_number] => 08241900 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-08-14 [patent_title] => 'mpl ligand' [patent_app_type] => utility [patent_app_number] => 08/422548 [patent_app_country] => US [patent_app_date] => 1995-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 41524 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 08422548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143972 [patent_doc_number] => 06063562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst' [patent_app_type] => 1 [patent_app_number] => 8/420003 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 17326 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063562.pdf [firstpage_image] =>[orig_patent_app_number] => 420003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759290 [patent_doc_number] => 05851829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Method of intracellular binding of target molecules' [patent_app_type] => 1 [patent_app_number] => 8/373190 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 34 [patent_no_of_words] => 29147 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851829.pdf [firstpage_image] =>[orig_patent_app_number] => 373190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022138 [patent_doc_number] => 05882853 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Method of evaluating HTLV-I-specific T cell responses' [patent_app_type] => 1 [patent_app_number] => 8/411142 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8200 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882853.pdf [firstpage_image] =>[orig_patent_app_number] => 411142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3503956 [patent_doc_number] => 05514542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Methods for propagating retrovirus for use in antibody assays' [patent_app_type] => 1 [patent_app_number] => 8/406826 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3765 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514542.pdf [firstpage_image] =>[orig_patent_app_number] => 406826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693533 [patent_doc_number] => 05660994 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Method of detecting tissue-specific, insoluble cytoskeletal proteins' [patent_app_type] => 1 [patent_app_number] => 8/396898 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10715 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 303 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/660/05660994.pdf [firstpage_image] =>[orig_patent_app_number] => 396898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3511640 [patent_doc_number] => 05576000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/388809 [patent_app_country] => US [patent_app_date] => 1995-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 4915 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576000.pdf [firstpage_image] =>[orig_patent_app_number] => 388809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3525959 [patent_doc_number] => 05582827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Process of screening plasma samples for effective antibody titers against respiratory viruses' [patent_app_type] => 1 [patent_app_number] => 8/378815 [patent_app_country] => US [patent_app_date] => 1995-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2409 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/582/05582827.pdf [firstpage_image] =>[orig_patent_app_number] => 378815 [rel_patent_id] =>[rel_patent_doc_number] =>)